BackOrion Biotech Opportunities Overview

Orion Biotech Opportunities Other Liabilities

Latest other liabilities for ORIA: $0.

Get informed when a big investor buys or sells

+ Follow
Other Liabilities
$0.00

Peer average

Loading

Orion Biotech Opportunities Other Liabilities History

Loading

Orion Biotech Opportunities vs. peers: Other Liabilities Comparison

Loading

Orion Biotech Opportunities Other Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Orion Biotech Opportunities (ORIA) FAQ

The latest other liabilities for ORIA is $0 as of December 2022. In the prior-year period, the figure was $0. Investors often review this figure alongside Orion Biotech Opportunities's historical trend and sector peers before judging valuation or financial health.

Over the past year, ORIA's other liabilities moved from $0 to $0. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Orion Biotech Opportunities's operating scale or balance-sheet position.

A other liabilities figure of $0 for ORIA is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting ORIA's other liabilities ($0), review year-over-year change from $0, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.